Capecitabine as Adjuvant Treatment for Stage III Colon Cancer-Reference-Cited by-同舟云学术

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

Published:2005-06-30 Issue:26 Volume:352 Page:2696-2704
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Twelves Chris,Wong Alfred,Nowacki Marek P.,Abt Markus,Burris Howard,Carrato Alfredo,Cassidy Jim,Cervantes Andrés,Fagerberg Jan,Georgoulias Vassilis,Husseini Fares,Jodrell Duncan,Koralewski Piotr,Kröning Hendrik,Maroun Jean,Marschner Norbert,McKendrick Joseph,Pawlicki Marek,Rosso Riccardo,Schüller Johannes,Seitz Jean-François,Stabuc Borut,Tujakowski Jerzy,Van Hazel Guy,Zaluski Jerzy,Scheithauer Werner

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa043116

Cited by 1070 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized controlled trial on the efficacy of topical urea-based cream in preventing capecitabine-associated hand-foot syndrome;2024-08-09

2. A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases;Frontiers in Pharmacology;2024-07-26

3. Evaluation of early fluoropyrimidine toxicity in solid organ cancer patients: a retrospective observational study in Australia;Internal Medicine Journal;2024-07-04

4. Two cases of metastatic colorectal cancer with prolonged liver injury following capecitabine combination chemotherapy;BMJ Case Reports;2024-07

5. Subdivision of pT1N0 (American Joint Committee on Cancer 8th edition) distal cholangiocarcinoma for adjuvant chemotherapy consideration;Journal of Hepato-Biliary-Pancreatic Sciences;2024-06-30